Ex parte PHIPPS et al. - Page 9




                Appeal No. 98-2769                                                                                                          
                Application 08/485,960                                                                                                      


                claim is also indefinite.   It follows that claims 2 through 5 which depend from claim 1 and claims 7                       

                through 10 which depend from claim 6 are also indefinite.                                                                   



                        Regarding independent claim 11, directed to “[a]n electrotransport device,” it is indicated that                    

                the device includes a controller which operates “at a predetermined, fixed electrical output” and which                     

                is adapted to be detachably connected, one at a time, to a plurality of therapeutic agent sources. In                       

                addition, claim 11 requires that the device include or have                                                                 



                       “a plurality of different classes of therapeutic agent sources in which a parameter in                              
                        each said different classes has been varied so that the electrotransport agent delivery                             
                        rate from the controller with one class of  therapeutic agent sources is substantially                              
                        different from the controller with another of said classes of therapeutic agent sources.”                           


                In this instance, we are at a loss to see how the claimed “electrotransport device” can be said to include                  

                “a plurality of different classes of therapeutic agent sources” when the device, in use, is disclosed as                    

                including only a single therapeutic agent source at a time, not a plurality.  Given this ambiguity, we agree                

                with the examiner that claim 11 is also indefinite. In addition, it follows that claims 12 through 20 which                 

                depend from claim 11 are also indefinite.                                                                                   






                                                                     9                                                                      





Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007